Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-05

Clinical Trial Update: Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pralatrexate in female patients with previously treated breast cancer has completed with results posted around 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pralatrexate (pralatrexate)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Breast Cancer, Breast Tumors | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05